ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹15 Cr | ₹16 Cr | ₹12 Cr | ₹14 Cr | ₹26 Cr |
What is the latest Total Non-Current Liabilities ratio of ALBERT DAVID ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹15 Cr |
Mar2024 | ₹16 Cr |
Mar2023 | ₹12 Cr |
Mar2022 | ₹14 Cr |
Mar2021 | ₹26 Cr |
How is Total Non-Current Liabilities of ALBERT DAVID Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹15 Cr | -7.59 | |
Mar2024 | ₹16 Cr | 34.17 | |
Mar2023 | ₹12 Cr | -17.53 | |
Mar2022 | ₹14 Cr | -43.56 | |
Mar2021 | ₹26 Cr | - |
Compare Total Non-Current Liabilities of peers of ALBERT DAVID
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALBERT DAVID | ₹464.4 Cr | 1.1% | -9.1% | -48.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,100.0 Cr | -5.6% | -9.9% | -12.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,698.0 Cr | -2.5% | -8.4% | 21.7% | Stock Analytics | |
CIPLA | ₹128,239.0 Cr | -0.8% | 1.8% | -1.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,216.0 Cr | -2.4% | -4% | 4.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,855.0 Cr | -0.3% | -0.9% | -9.7% | Stock Analytics |
ALBERT DAVID Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALBERT DAVID | 1.1% |
-9.1% |
-48.5% |
SENSEX | -1.2% |
-1.2% |
-1.7% |
You may also like the below Video Courses